| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neurosense Therapeutics Ltd. (NRSNW) has 3 insiders with recent SEC Form 4 filings, including 2 buys and 0 sells.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 4.53M | $411.3K | +250.0K | |
| CFO | 1.50M | $136.4K | +250.0K | |
| Other | 521.8K | $47.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | Eisenberg Or | Chief Financial Officer | Buy | 250,000 | $0.80 | $200,000.00 | +19.9% | - | - | |
| Jun 16, 2026 | Ben-Noon Alon | Chief Executive Officer | Buy | 250,000 | $0.80 | $200,000.00 | +5.8% | - | - |